zolpidem has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clarify the effects of zolpidem, a gamma-aminobutyric acid (GABA)(A) receptor agonist, on bladder function, and urine production, we investigated the effects of zolpidem administration on bladder overactivity induced by cerebral infarction (CI) and on urine excretion increased by water overloading in Wistar rats." | 3.76 | Zolpidem increases bladder capacity and decreases urine excretion in rats. ( Matsuta, Y; Ohtake, A; Sasamata, M; Suzuki, M; Watanabe, M; Yanai-Inamura, H; Yokoyama, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, O | 1 |
| Matsuta, Y | 1 |
| Yanai-Inamura, H | 1 |
| Watanabe, M | 1 |
| Ohtake, A | 1 |
| Suzuki, M | 1 |
| Sasamata, M | 1 |
1 other study available for zolpidem and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Zolpidem increases bladder capacity and decreases urine excretion in rats.
Topics: Aldosterone; Animals; Bicuculline; Cerebral Infarction; Disease Models, Animal; Dose-Response Relati | 2010 |